Ozempic and Jardiance are effective therapies in the management of Type 2 diabetes, but selection of one agent over another requires consideration of a number of factors like concomitant medical conditions, other medications currently prescribed, and risk for the development of serious side effects
In todays PAAD we will review an original article by Pai et al
Furthermore, in a randomized, double-blind, placebo-controlled study enrolling 70 patients with AD aged 6 to 12 years, the administration of melatonin (6 mg daily) demonstrated to improve SCORAD ( p = 0.007), objective SCORAD ( p = 0.001), serum total IgE levels ( p = 0.005) and Childrens Sleep Habits Questionnaire scores ( p = 0.006) at 6 weeks (40)
These formulations are engineered to match each species pharmacokinetics, metabolism, and safety thresholds, making them safer than human NSAIDs
Amniotic fluid tumor necrosis factor- and the risk of respiratory distress syndrome among preterm infants